FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
RBC Capital analyst Gregory Renza raised the price target on Amgen (NASDAQ: AMGN) to $362.00 (from $332.00) while maintaining a Outperform rating.
The analyst comments "MariTide and the obesity portfolio continue to dominate the narrative following the recent "encouraging" interim data look amidst the... More

